v3.26.1
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT - USD ($)
$ in Thousands
Ordinary Shares
Capital in Excess of Par Value
Treasury Shares
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Total
Beginning Equity Balance at Dec. 31, 2024 $ 3 $ 773,565   $ (3,719) $ (702,022) $ 67,827
Beginning Equity Balance (shares) at Dec. 31, 2024 78,397,380          
Share-based compensation activity   2,130       2,130
Share-based compensation activity (shares) 457,679          
Issuance of ordinary shares in at-the-market offering   4,482       4,482
Issuance of ordinary shares in at-the-market offering (shares) 563,379          
Issuance costs in connection with ordinary shares   (12)       (12)
Other comprehensive gain (loss)       (1,347)   (1,347)
Net loss for the period         (39,981) (39,981)
Ending Equity Balance at Mar. 31, 2025 $ 3 780,165   (5,066) (742,003) 33,099
Ending Equity Balance (shares) at Mar. 31, 2025 79,418,438          
Beginning Equity Balance at Dec. 31, 2025 $ 3 808,021   2,406 (816,223) $ (5,793)
Beginning Equity Balance (shares) at Dec. 31, 2025 81,120,931         81,120,931
Share-based compensation activity   (2,244)       $ (2,244)
Share-based compensation activity (shares) 824,466          
Issuance of ordinary shares in at-the-market offering   14,027       14,027
Issuance of ordinary shares in at-the-market offering (shares) 1,770,729          
Issuance costs in connection with ordinary shares   (35)       (35)
Repurchase of treasury shares     $ (18,193)     (18,193)
Repurchase of treasury shares (shares) (2,300,000)          
Issuance of ordinary shares in connection with license agreement   249       249
Issuance of ordinary shares in connection with license agreement (shares) 30,000          
Other comprehensive gain (loss)       172   172
Net loss for the period         (46,313) (46,313)
Ending Equity Balance at Mar. 31, 2026 $ 3 $ 820,018 $ (18,193) $ 2,578 $ (862,536) $ (58,130)
Ending Equity Balance (shares) at Mar. 31, 2026 81,446,126         81,446,126